Percutaneous and surgical treatment of pyogenic liver abscesses: Observation over a 21-year period in 148 patients

G. Ferraioli, A. Garlaschelli, D. Zanaboni, R. Gulizia, E. Brunetti, F. P. Tinozzi, C. Cammà, C. Filice

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Percutaneous drainage of pyogenic liver abscess has become first-line treatment. In the past surgical drainage was preferred in some centres. Aim: The aim of this retrospective study was to assess the effectiveness of percutaneous treatments and surgical drainage, in terms of treatment success, hospital stay and costs. Patients: Data of 148 patients (90 males; 58 females; mean age, 61 yrs; range, 30-86 yrs) were retrospectively analysed. Methods: Patients' outcomes, including the length of hospital stay, procedure-related complications, treatment failure and death, were recorded. Multiple logistic regression model was used for statistical analysis. Results: One hundred and four patients (83 with solitary and 21 with multiple abscesses) were treated percutaneously, either by needle aspiration (91 patients) or catheter drainage (13 patients) depending on the abscess's size, and 44 patients (30 with solitary and 14 with multiple abscesses) were treated surgically. There was no statistically significant difference in patients' demographics or abscess characteristics between groups. Hospital stay was longer, and costs were higher in patients treated surgically (p <0.001). There was statistically significant difference in morbidity rate between groups (p <0.001). No death occurred in both groups. Conclusions: Percutaneous and surgical treatment of pyogenic liver abscesses are both effective, nevertheless percutaneous drainage carries lower morbidity and is cheaper.

Original languageEnglish
Pages (from-to)690-696
Number of pages7
JournalDigestive and Liver Disease
Volume40
Issue number8
DOIs
Publication statusPublished - Aug 2008

Fingerprint

Pyogenic Liver Abscess
Observation
Drainage
Abscess
Length of Stay
Therapeutics
Logistic Models
Morbidity
Hospital Costs
Treatment Failure
Needles
Catheters
Retrospective Studies
Demography

Keywords

  • Drainage
  • Interventional procedure
  • Liver
  • Liver abscess
  • Retrospective studies
  • Treatment outcome
  • Ultrasound

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{7443ee8d72c44c14a06eaa6613b3591b,
title = "Percutaneous and surgical treatment of pyogenic liver abscesses: Observation over a 21-year period in 148 patients",
abstract = "Background: Percutaneous drainage of pyogenic liver abscess has become first-line treatment. In the past surgical drainage was preferred in some centres. Aim: The aim of this retrospective study was to assess the effectiveness of percutaneous treatments and surgical drainage, in terms of treatment success, hospital stay and costs. Patients: Data of 148 patients (90 males; 58 females; mean age, 61 yrs; range, 30-86 yrs) were retrospectively analysed. Methods: Patients' outcomes, including the length of hospital stay, procedure-related complications, treatment failure and death, were recorded. Multiple logistic regression model was used for statistical analysis. Results: One hundred and four patients (83 with solitary and 21 with multiple abscesses) were treated percutaneously, either by needle aspiration (91 patients) or catheter drainage (13 patients) depending on the abscess's size, and 44 patients (30 with solitary and 14 with multiple abscesses) were treated surgically. There was no statistically significant difference in patients' demographics or abscess characteristics between groups. Hospital stay was longer, and costs were higher in patients treated surgically (p <0.001). There was statistically significant difference in morbidity rate between groups (p <0.001). No death occurred in both groups. Conclusions: Percutaneous and surgical treatment of pyogenic liver abscesses are both effective, nevertheless percutaneous drainage carries lower morbidity and is cheaper.",
keywords = "Drainage, Interventional procedure, Liver, Liver abscess, Retrospective studies, Treatment outcome, Ultrasound",
author = "G. Ferraioli and A. Garlaschelli and D. Zanaboni and R. Gulizia and E. Brunetti and Tinozzi, {F. P.} and C. Camm{\`a} and C. Filice",
year = "2008",
month = "8",
doi = "10.1016/j.dld.2008.01.016",
language = "English",
volume = "40",
pages = "690--696",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "8",

}

TY - JOUR

T1 - Percutaneous and surgical treatment of pyogenic liver abscesses

T2 - Observation over a 21-year period in 148 patients

AU - Ferraioli, G.

AU - Garlaschelli, A.

AU - Zanaboni, D.

AU - Gulizia, R.

AU - Brunetti, E.

AU - Tinozzi, F. P.

AU - Cammà, C.

AU - Filice, C.

PY - 2008/8

Y1 - 2008/8

N2 - Background: Percutaneous drainage of pyogenic liver abscess has become first-line treatment. In the past surgical drainage was preferred in some centres. Aim: The aim of this retrospective study was to assess the effectiveness of percutaneous treatments and surgical drainage, in terms of treatment success, hospital stay and costs. Patients: Data of 148 patients (90 males; 58 females; mean age, 61 yrs; range, 30-86 yrs) were retrospectively analysed. Methods: Patients' outcomes, including the length of hospital stay, procedure-related complications, treatment failure and death, were recorded. Multiple logistic regression model was used for statistical analysis. Results: One hundred and four patients (83 with solitary and 21 with multiple abscesses) were treated percutaneously, either by needle aspiration (91 patients) or catheter drainage (13 patients) depending on the abscess's size, and 44 patients (30 with solitary and 14 with multiple abscesses) were treated surgically. There was no statistically significant difference in patients' demographics or abscess characteristics between groups. Hospital stay was longer, and costs were higher in patients treated surgically (p <0.001). There was statistically significant difference in morbidity rate between groups (p <0.001). No death occurred in both groups. Conclusions: Percutaneous and surgical treatment of pyogenic liver abscesses are both effective, nevertheless percutaneous drainage carries lower morbidity and is cheaper.

AB - Background: Percutaneous drainage of pyogenic liver abscess has become first-line treatment. In the past surgical drainage was preferred in some centres. Aim: The aim of this retrospective study was to assess the effectiveness of percutaneous treatments and surgical drainage, in terms of treatment success, hospital stay and costs. Patients: Data of 148 patients (90 males; 58 females; mean age, 61 yrs; range, 30-86 yrs) were retrospectively analysed. Methods: Patients' outcomes, including the length of hospital stay, procedure-related complications, treatment failure and death, were recorded. Multiple logistic regression model was used for statistical analysis. Results: One hundred and four patients (83 with solitary and 21 with multiple abscesses) were treated percutaneously, either by needle aspiration (91 patients) or catheter drainage (13 patients) depending on the abscess's size, and 44 patients (30 with solitary and 14 with multiple abscesses) were treated surgically. There was no statistically significant difference in patients' demographics or abscess characteristics between groups. Hospital stay was longer, and costs were higher in patients treated surgically (p <0.001). There was statistically significant difference in morbidity rate between groups (p <0.001). No death occurred in both groups. Conclusions: Percutaneous and surgical treatment of pyogenic liver abscesses are both effective, nevertheless percutaneous drainage carries lower morbidity and is cheaper.

KW - Drainage

KW - Interventional procedure

KW - Liver

KW - Liver abscess

KW - Retrospective studies

KW - Treatment outcome

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=45849092570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45849092570&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2008.01.016

DO - 10.1016/j.dld.2008.01.016

M3 - Article

C2 - 18337194

AN - SCOPUS:45849092570

VL - 40

SP - 690

EP - 696

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 8

ER -